
Elagox150 mg
Nuvista Pharma Ltd.
Elagolix is an oral gonadotropin-releasing hormone (GnRH) antagonist indicated for the following use: FDA-approved/established use: Management of moderate to severe pain associated with…
Elagolix is an oral gonadotropin-releasing hormone (GnRH) antagonist indicated for the following use:
Elagolix is not approved or indicated for use in men, in pediatric patients, as a contraceptive, or for any condition other than endometriosis-associated pain.
Dosing of Elagolix depends on treatment duration and use of other medications:
| Regimen | Dose | Maximum Duration |
|---|---|---|
| Standard dose | 150 mg orally once daily | Up to 24 months |
| Higher dose (more severe pain) | 200 mg orally twice daily | Up to 6 months |
Elagolix should be taken at approximately the same time each day, with or without food, swallowed whole with water, and initiated within the first 5 days of the onset of menses.
See Duration of Treatment and Use in Special Populations for dose adjustment in hepatic impairment.
Common side effects reported with Elagolix include:
See Precautions and Warnings for information on bone mineral density (BMD) loss associated with Elagolix.
Elagolix is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.